KING OF PRUSSIA, Pa., April 25, 2022 /PRNewswire/ --
As calculated on the attached Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our funds from operations ("FFO"), were
The decrease in our net income of
During the first quarter of 2022, as compared to the first quarter of 2021, our FFO decreased
The first quarter dividend of
At
During the first quarter of 2022, we completed the following acquisitions utilizing qualified third-party intermediaries as part of a series of anticipated tax-deferred-like-kind exchange transactions pursuant to Section 1031 of the Internal Revenue Code, as amended:
As previously disclosed on Form 8-K as filed on
The properties acquired by us in connection with the asset purchase and sale agreement with UHS were accounted for as financing arrangements and our consolidated balance sheet as of
Also as previously disclosed, the lease on the specialty hospital located in
We estimate that the aggregate operating expenses for the three vacant specialty facilities, including the facility located in
This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed herein, those related to the anticipated impact of COVID-19 on our financial results, as well as the operations and financial results of each of our tenants, those related to healthcare industry trends and those detailed in our filings with the
Many of the factors that could affect our future results are beyond our control or ability to predict, including the impact of the COVID-19 pandemic. Future operations and financial results of our tenants, and in turn ours, could be materially impacted by developments related to COVID-19. Such developments include, but are not limited to, the length of time and severity of the spread of the pandemic; the volume of cancelled or rescheduled elective procedures and the volume of COVID-19 patients treated by the operators of our hospitals and other healthcare facilities; measures our tenants are taking to respond to the COVID-19 pandemic; the impact of government and administrative regulation and stimulus on the health care industry; declining patient volumes and unfavorable changes in payer mix caused by deteriorating macroeconomic conditions (including increases in uninsured and underinsured patients as the result of business closings and layoffs); potential disruptions to clinical staffing and shortages and disruptions related to supplies required for our tenants’ employees and patients; and potential increases to expenses incurred by our tenants related to staffing, supply chain or other expenditures. Due to COVID-19 restrictions and its impact on the economy, we may experience a decrease in prospective tenants which could unfavorably impact the volume of new leases, as well as the renewal rate of existing leases. The COVID-19 pandemic may delay our construction projects which could result in increased costs and delay the timing of opening and rental payments from those projects, although no such delays have yet occurred. The COVID-19 pandemic could also impact our indebtedness and the ability to refinance such indebtedness on acceptable terms, as well as risks associated with disruptions in the financial markets and the business of financial institutions as the result of the COVID-19 pandemic which could impact us from a financing perspective; and changes in general economic conditions nationally and regionally in the markets our properties are located resulting from the COVID-19 pandemic. We are not able to quantify the impact that these factors will have on our future operations, but developments related to the COVID-19 pandemic could have a material adverse impact on our future financial results.
We believe that, if and when applicable, adjusted net income and adjusted net income per diluted share (as reflected on the Supplemental Schedule), which are non-GAAP financial measures ("GAAP" is Generally Accepted Accounting Principles in
Funds from operations ("FFO") is a widely recognized measure of performance for Real Estate Investment Trusts ("REITs"). We believe that FFO and FFO per diluted share, which are non-GAAP financial measures, are helpful to our investors as measures of our operating performance. We compute FFO, as reflected on the attached Supplemental Schedules, in accordance with standards established by the
To obtain a complete understanding of our financial performance these measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed consolidated financial statements and notes thereto in this report or in our other filings with the
(more)
Universal Health Realty Income Trust | ||||||||
Consolidated Statements of Income | ||||||||
For the Three Months Ended | ||||||||
(amounts in thousands, except share information) | ||||||||
(unaudited) | ||||||||
Three Months Ended | ||||||||
2022 | 2021 | |||||||
Revenues: | ||||||||
Lease revenue - UHS facilities (a.) | $ | 7,426 | $ | 7,132 | ||||
Lease revenue - Non-related parties | 12,895 | 13,092 | ||||||
Other revenue - UHS facilities | 229 | 226 | ||||||
Other revenue - Non-related parties | 255 | 249 | ||||||
Interest income on financing leases - UHS facilities | 1,370 | - | ||||||
22,175 | 20,699 | |||||||
Expenses: | ||||||||
Depreciation and amortization | 6,709 | 6,787 | ||||||
Advisory fees to UHS | 1,224 | 1,062 | ||||||
Other operating expenses | 6,867 | 5,602 | ||||||
14,800 | 13,451 | |||||||
Income before equity in income of unconsolidated limited liability companies ("LLCs") and interest expense | 7,375 | 7,248 | ||||||
Equity in income of unconsolidated LLCs | 252 | 471 | ||||||
Interest expense, net | (2,222) | (2,133) | ||||||
Net income | $ | 5,405 | $ | 5,586 | ||||
Basic earnings per share | $ | 0.39 | $ | 0.41 | ||||
Diluted earnings per share | $ | 0.39 | $ | 0.41 | ||||
Weighted average number of shares outstanding - Basic | 13,764 | 13,750 | ||||||
Weighted average number of shares outstanding - Diluted | 13,785 | 13,771 | ||||||
(a.) Includes bonus rental on |
Universal Health Realty Income Trust | ||||||||||||||||
Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule") | ||||||||||||||||
For the Three Months Ended | ||||||||||||||||
(amounts in thousands, except share information) | ||||||||||||||||
(unaudited) | ||||||||||||||||
Calculation of Adjusted Net Income | ||||||||||||||||
Three Months Ended | Three Months Ended | |||||||||||||||
March 31, 2022 | March 31, 2021 | |||||||||||||||
Amount | Per Diluted Share | Amount | Per Diluted Share | |||||||||||||
Net income | $ | 5,405 | $ | 0.39 | $ | 5,586 | $ | 0.41 | ||||||||
Adjustments | - | - | - | - | ||||||||||||
Subtotal adjustments to net income | - | - | - | - | ||||||||||||
Adjusted net income | $ | 5,405 | $ | 0.39 | $ | 5,586 | $ | 0.41 |
Calculation of Funds From Operations ("FFO") | ||||||||||||||||
Three Months Ended | Three Months Ended | |||||||||||||||
March 31, 2022 | March 31, 2021 | |||||||||||||||
Amount | Per Diluted Share | Amount | Per Diluted Share | |||||||||||||
Net income | $ | 5,405 | $ | 0.39 | $ | 5,586 | $ | 0.41 | ||||||||
Plus: Depreciation and amortization expense: | ||||||||||||||||
Consolidated investments | 6,709 | 0.49 | 6,787 | 0.49 | ||||||||||||
Unconsolidated affiliates | 295 | 0.02 | 362 | 0.02 | ||||||||||||
FFO | $ | 12,409 | $ | 0.90 | $ | 12,735 | $ | 0.92 | ||||||||
Dividend paid per share | $ | 0.705 | $ | 0.695 |
Universal Health Realty Income Trust | ||||||||
Consolidated Balance Sheets | ||||||||
(amounts in thousands, except share information) | ||||||||
(unaudited) | ||||||||
2022 | 2021 | |||||||
Assets: | ||||||||
Real Estate Investments: | ||||||||
Buildings and improvements and construction in progress | $ | 622,757 | $ | 608,836 | ||||
Accumulated depreciation | (231,459) | (225,584) | ||||||
391,298 | 383,252 | |||||||
Land | 56,631 | 54,897 | ||||||
Net Real Estate Investments | 447,929 | 438,149 | ||||||
Financing receivable from UHS | 83,741 | 82,439 | ||||||
Net Real Estate Investments and Financing receivable | 531,670 | 520,588 | ||||||
Investments in and advances to limited liability companies ("LLCs") | 9,960 | 10,139 | ||||||
Other Assets: | ||||||||
Cash and cash equivalents | 8,879 | 22,504 | ||||||
Lease and other receivables from UHS | 4,397 | 4,641 | ||||||
Lease receivable - other | 7,763 | 7,109 | ||||||
Intangible assets (net of accumulated amortization of | 11,175 | 9,972 | ||||||
Right-of-use land assets, net | 11,486 | 11,495 | ||||||
Deferred charges and other assets, net | 17,119 | 11,971 | ||||||
Total Assets | $ | 602,449 | $ | 598,419 | ||||
Liabilities: | ||||||||
Line of credit borrowings | $ | 275,100 | $ | 271,900 | ||||
Mortgage notes payable, non-recourse to us, net | 56,346 | 56,866 | ||||||
Accrued interest | 343 | 346 | ||||||
Accrued expenses and other liabilities | 11,779 | 12,157 | ||||||
Ground lease liabilities, net | 11,486 | 11,495 | ||||||
Tenant reserves, deposits and deferred and prepaid rents | 10,421 | 10,328 | ||||||
Total Liabilities | 365,475 | 363,092 | ||||||
Equity: | ||||||||
Preferred shares of beneficial interest, none issued and outstanding | - | - | ||||||
Common shares, 95,000,000 shares authorized; issued and outstanding: 2022 - 13,786,277; 2021 - 13,785,345 | 138 | 138 | ||||||
Capital in excess of par value | 268,792 | 268,515 | ||||||
Cumulative net income | 794,964 | 789,559 | ||||||
Cumulative dividends | (833,717) | (823,998) | ||||||
Accumulated other comprehensive income | 6,797 | 1,113 | ||||||
Total Equity | 236,974 | 235,327 | ||||||
Total Liabilities and Equity | $ | 602,449 | $ | 598,419 |
View original content:https://www.prnewswire.com/news-releases/universal-health-realty-income-trust-reports-2022-first-quarter-financial-results-301532295.html
SOURCE
Universal Health Realty Income Trust
Symbol: UHT
CIK: 798783
Exchange: NYSE
Founded: 1986 (37 years)
Type of REIT: Equity REIT
Listing Status: Public
Market Capitalization: Small-Cap
REIT Sector: Health Care
REITRating is REITNote's Real Estate Investment Trust industry-specific rating and ranking system. The overall score is out of ten points, with ten being the best score.
Latest Price: $41.14
High: $41.20
Low: $40.69
Open: $40.75
Previous Close: $41.16
Volume: 24,300
52-Week High: $54.97
52-Week Low: $38.56
Last updated: 2023-09-25 - v0.6